Drug Database
Back to search

Norway· NO-ID_BB900F91-E2DF-424B-A272-B0769D985A79

Visipaque

A iodixanol product containing iodixanol, registered in Norway by GE Healthcare AS. The same ATC class is registered in 16 of our 19 countries.

ATC V08AB09

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedVisipaqueATCV08AB09REGISTER NO.NO-ID_BB900F91-E2DF-4…PACKS LISTED9CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iodixanolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iodixanol is registered in 16 of 19 countries.

Countries holding a registration under ATC V08AB09 (iodixanol), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose
Search iodixanol products by name

Iodixanol · ATC V08AB09

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Iodixanol
Manufacturer
GE Healthcare AS
Country
Norway (NO)
ATC code
V08AB09
ATC class
Iodixanol
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 9

4 priced
  • no_varenummer
    583518
    10 x 100
    NOK 3630.6
  • no_varenummer
    019132
    10 x 50
    NOK 2581.5
  • no_varenummer
    583609
    10 x 200
    NOK 7225
  • no_merkevare_id
    ID_BB900F91-E2DF-424B-A272-B0769D985A79
  • no_varenummer
    583708
    6 x 500
    NOK 10819.3
  • gtin
    7046265837084
  • gtin
    7046265835189
  • gtin
    7046260191327
  • gtin
    7046265836094

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for iodixanol.

Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iodixanol against other medicinesHow interaction checks work

Iodixanol · interactions on record

172 records

  • 87 severe
  • 50 moderate
  • 35 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iodixanol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodixanol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Visipaque
  • Belgium · Visipaque
  • Bulgaria · Визипак
  • Cyprus · Visipaque
  • Czechia · Visipaque
  • Germany · Visipaque
  • Denmark · Visipaque
  • Estonia · Visipaque
  • Spain · Visipaque
  • Finland · Visipaque
  • France · Visipaque
  • United Kingdom (Northern Ireland) · Visipaque
  • Greece · Visipaque
  • Croatia · Visipaque
  • Hungary · Visipaque
  • Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
  • Iceland · Visipaque
  • Italy · Visipaque
  • Lithuania · Visipaque
  • Luxembourg · Visipaque
  • Latvia · Visipaque
  • Malta · Visipaque
  • Netherlands · Visipaque
  • Poland · Visipaque
  • Portugal · Visipaque
  • Romania · Visipaque
  • Sweden · Visipaque
  • Slovenia · Visipaque
  • Slovakia · Visipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/17de00f1-c447-41ce-8454-8e4457b78f09
GET /v1/drugs/17de00f1-c447-41ce-8454-8e4457b78f09?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Jodiksanol",
  "merkevare_id": "ID_BB900F91-E2DF-424B-A272-B0769D985A79",
  "name_form_strength": "Visipaque inj, oppl 320 mg I/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about iodixanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console